Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evonik is one of the world’s leading specialty chemicals companies with a major focus on healthcare solutions. Its Health Care business unit serves over a thousand life science customers globally—including more than ninety percent of the world’s top pharmaceutical companies—by providing advanced excipients, proprietary drug delivery technologies, cell culture solutions, and comprehensive CDMO/CMO services. The company has decades-long expertise in oral and parenteral drug delivery systems such as EUDRAGIT®, RESOMER®, lipid-based formulations for mRNA therapeutics/vaccines, high-purity amino acids/proteins/peptides for cell culture media and bioprocessing. It played an important role during the COVID pandemic by supplying critical lipids used in mRNA vaccines. Recent investments include new R&D hubs in Boston/Cambridge MA and Allentown PA plus large-scale lipid production facilities to support next-generation medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evonik.